Exact Mass: 357.1376

Exact Mass Matches: 357.1376

Found 87 metabolites which its exact mass value is equals to given mass value 357.1376, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bakankoside

Bakankoside

C16H23NO8 (357.1424)


   

9-Thiocyanato-androst-4-ene-3,11,17-trione

9-Thiocyanato-androst-4-ene-3,11,17-trione

C20H23NO3S (357.1399)


   

Cyhalofop-butyl

Cyhalofop-butyl

C20H20FNO4 (357.1376)


CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8186; ORIGINAL_PRECURSOR_SCAN_NO 8182 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8182; ORIGINAL_PRECURSOR_SCAN_NO 8179 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3852 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3851 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3828; ORIGINAL_PRECURSOR_SCAN_NO 3825 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8179; ORIGINAL_PRECURSOR_SCAN_NO 8176 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3830; ORIGINAL_PRECURSOR_SCAN_NO 3828 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8167; ORIGINAL_PRECURSOR_SCAN_NO 8165 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8182; ORIGINAL_PRECURSOR_SCAN_NO 8180 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8172; ORIGINAL_PRECURSOR_SCAN_NO 8170 CONFIDENCE standard compound; INTERNAL_ID 747; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3829; ORIGINAL_PRECURSOR_SCAN_NO 3826

   

Haloperidol 1,2,3,6-tetrahydropyridine

4(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine hydrochloride

C21H21ClFNO (357.1296)


Haloperidol 1,2,3,6-tetrahydropyridine is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)

   

3-[Bis(4-methoxyphenyl)methylidene]-1H-indol-2-one

3-[bis(4-methoxyphenyl)methylidene]-2,3-dihydro-1H-indol-2-one

C23H19NO3 (357.1365)


   

SCHEMBL3300409

SCHEMBL3300409

C20H20FNO4 (357.1376)


   

Nitrodenafil

Nitrodenafil

C17H19N5O4 (357.1437)


   

SCHEMBL1079103

SCHEMBL1079103

C15H23N3O5S (357.1358)


   

His Val Cys

His Val Cys

C14H23N5O4S (357.1471)


   

Val Cys His

Val Cys His

C14H23N5O4S (357.1471)


   

His Met Ala

His Met Ala

C14H23N5O4S (357.1471)


   

Ser His Asp

Ser His Asp

C13H19N5O7 (357.1284)


   

His Ala Met

His Ala Met

C14H23N5O4S (357.1471)


   

Ser Asp His

Ser Asp His

C13H19N5O7 (357.1284)


   

Ala His Met

Ala His Met

C14H23N5O4S (357.1471)


   

Ala Met His

Ala Met His

C14H23N5O4S (357.1471)


   

His Asp Ser

His Asp Ser

C13H19N5O7 (357.1284)


   

Met Ala His

Met Ala His

C14H23N5O4S (357.1471)


   

Asp His Ser

Asp His Ser

C13H19N5O7 (357.1284)


   

Cys Val His

Cys Val His

C14H23N5O4S (357.1471)


   

His Ser Asp

His Ser Asp

C13H19N5O7 (357.1284)


   

His Cys Val

His Cys Val

C14H23N5O4S (357.1471)


   

Asp Ser His

Asp Ser His

C13H19N5O7 (357.1284)


   

Met His Ala

Met His Ala

C14H23N5O4S (357.1471)


   

Cys His Val

Cys His Val

C14H23N5O4S (357.1471)


   

Benzyladenosine

(2R,3R,4S,5R)-2-(6-(benzylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol

C17H19N5O4 (357.1437)


N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5]. N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5]. N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma[1]-[5].

   

Carabersat

Carabersat

C20H20FNO4 (357.1376)


CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3829; ORIGINAL_PRECURSOR_SCAN_NO 3826 C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3735; ORIGINAL_PRECURSOR_SCAN_NO 3733 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3830; ORIGINAL_PRECURSOR_SCAN_NO 3828 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3784; ORIGINAL_PRECURSOR_SCAN_NO 3782 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3852 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8151; ORIGINAL_PRECURSOR_SCAN_NO 8147 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8221; ORIGINAL_PRECURSOR_SCAN_NO 8218 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8179; ORIGINAL_PRECURSOR_SCAN_NO 8176 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8256; ORIGINAL_PRECURSOR_SCAN_NO 8254 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8172; ORIGINAL_PRECURSOR_SCAN_NO 8170 CONFIDENCE standard compound; INTERNAL_ID 1152; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8204; ORIGINAL_PRECURSOR_SCAN_NO 8203

   

O6-Benzyl-deoxyguanosine

O6-Benzyl-deoxyguanosine

C17H19N5O4 (357.1437)


   

4-nitrobenzo-18-crown-6

"MLS001047529-01!3-(diethylamino)propyl 2,2-diphenylacetate"

C16H23NO8 (357.1424)


   

Met Ala His

Met Ala His

C14H23N5O4S1 (357.1471)


   

His Val Cys

His Val Cys

C14H23N5O4S1 (357.1471)


   

Cys Val His

Cys Val His

C14H23N5O4S1 (357.1471)


   

His Ala Met

His Ala Met

C14H23N5O4S1 (357.1471)


   

Ala Met His

Ala Met His

C14H23N5O4S1 (357.1471)


   

His Cys Val

His Cys Val

C14H23N5O4S1 (357.1471)


   

Val His Cys

Val His Cys

C14H23N5O4S1 (357.1471)


   

Val Cys His

Val Cys His

C14H23N5O4S1 (357.1471)


   

Cys His Val

Cys His Val

C14H23N5O4S1 (357.1471)


   

Ala His Met

Ala His Met

C14H23N5O4S1 (357.1471)


   

Met His Ala

Met His Ala

C14H23N5O4S1 (357.1471)


   

His Met Ala

His Met Ala

C14H23N5O4S1 (357.1471)


   

JWH 073 N-butanoic acid metabolite

4-(3-(1-naphthoyl)-1H-indol-1-yl)-butanoic acid

C23H19NO3 (357.1365)


   

Isradipine Metabolite (2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.)

3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, mono(1-methylethyl) ester

C18H19N3O5 (357.1325)


   

Ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(1-T-butoxycarbonyl-1-methyl)ethoxyimino acetate

Ethyl (Z)-2-(2-aminothiazol-4-yl)-2-(1-T-butoxycarbonyl-1-methyl)ethoxyimino acetate

C15H23N3O5S (357.1358)


   

4-CHLORO-N-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE

4-CHLORO-N-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE

C18H20ClN5O (357.1356)


   

(4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE

(4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE

C20H20FNO4 (357.1376)


   

1-(5-methoxy-2-methyl-4-nitrophenyl)-4-(2-methylsulfonylethyl)piperazine

1-(5-methoxy-2-methyl-4-nitrophenyl)-4-(2-methylsulfonylethyl)piperazine

C15H23N3O5S (357.1358)


   

5-(aminosulphonyl)-N-[[1-(2-hydroxyethyl)-2-pyrrolidinyl]methyl]-2-methoxybenzamide

5-(aminosulphonyl)-N-[[1-(2-hydroxyethyl)-2-pyrrolidinyl]methyl]-2-methoxybenzamide

C15H23N3O5S (357.1358)


   

8-benzyloxy-2-deoxyadenosine

8-benzyloxy-2-deoxyadenosine

C17H19N5O4 (357.1437)


   

4-TERT-BUTOXYCARBONYLAMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID BENZOTRIAZOL-1YL ESTER

4-TERT-BUTOXYCARBONYLAMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID BENZOTRIAZOL-1YL ESTER

C17H19N5O4 (357.1437)


   

(4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one

(4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one

C20H20FNO4 (357.1376)


   

(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

C20H20FNO4 (357.1376)


   

7-Chloro-N-(4-fluoro-3-{[(2-methyl-2-propanyl)amino]methyl}phenyl )-4-quinolinamine

7-Chloro-N-(4-fluoro-3-{[(2-methyl-2-propanyl)amino]methyl}phenyl )-4-quinolinamine

C20H21ClFN3 (357.1408)


   

6-Cyclohexylmethoxy-2-(3-chloroanilino) purine

6-Cyclohexylmethoxy-2-(3-chloroanilino) purine

C18H20ClN5O (357.1356)


   

4-(4-(4-Chlorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-1-(4-fluorophenyl)-1-butanone

4-(4-(4-Chlorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-1-(4-fluorophenyl)-1-butanone

C21H21ClFNO (357.1296)


   

3-[Bis(4-methoxyphenyl)methylidene]-1H-indol-2-one

3-[Bis(4-methoxyphenyl)methylidene]-1H-indol-2-one

C23H19NO3 (357.1365)


   

L-Aspartic acid, L-histidyl-L-seryl-

L-Aspartic acid, L-histidyl-L-seryl-

C13H19N5O7 (357.1284)


   

[2-(aminooxy)ethyl]{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}methylsulfonium (non-preferred name)

[2-(aminooxy)ethyl]{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}methylsulfonium (non-preferred name)

C13H21N6O4S+ (357.1345)


   

(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One

(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One

C17H19N5O4 (357.1437)


   

4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide

4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide

C18H19N3O5 (357.1325)


   

5-(2-Furanyl)-2-[(2-phenylanilino)methylidene]cyclohexane-1,3-dione

5-(2-Furanyl)-2-[(2-phenylanilino)methylidene]cyclohexane-1,3-dione

C23H19NO3 (357.1365)


   

(2-Aminooxy-ethyl)-[5-(6-amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-methyl-sulfonium

(2-Aminooxy-ethyl)-[5-(6-amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-methyl-sulfonium

C13H21N6O4S+ (357.1345)


   

N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide

N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide

C18H19N3O5 (357.1325)


   

1-[2-(2,5-dimethyl-1H-indol-3-yl)ethyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea

1-[2-(2,5-dimethyl-1H-indol-3-yl)ethyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea

C19H23N3S2 (357.1333)


   

2-(Diphenylphosphanyl)-1-(2-methoxyphenyl)-1H-pyrrole

2-(Diphenylphosphanyl)-1-(2-methoxyphenyl)-1H-pyrrole

C23H20NOP (357.1282)


   

Ser-His-Asp

Ser-His-Asp

C13H19N5O7 (357.1284)


   

Asp-His-Ser

Asp-His-Ser

C13H19N5O7 (357.1284)


   

Asp-Ser-His

Asp-Ser-His

C13H19N5O7 (357.1284)


   

His-Asp-Ser

His-Asp-Ser

C13H19N5O7 (357.1284)


   

Ser-Asp-His

Ser-Asp-His

C13H19N5O7 (357.1284)


   

Ala-His-Met

Ala-His-Met

C14H23N5O4S (357.1471)


   

Ala-Met-His

Ala-Met-His

C14H23N5O4S (357.1471)


   

Cys-Val-His

Cys-Val-His

C14H23N5O4S (357.1471)


   

His-Val-Cys

His-Val-Cys

C14H23N5O4S (357.1471)


   

Met-His-Ala

Met-His-Ala

C14H23N5O4S (357.1471)


   

Cys-His-Val

Cys-His-Val

C14H23N5O4S (357.1471)


   

His-Ala-Met

His-Ala-Met

C14H23N5O4S (357.1471)


   

His-Cys-Val

His-Cys-Val

C14H23N5O4S (357.1471)


   

His-Met-Ala

His-Met-Ala

C14H23N5O4S (357.1471)


   

Met-Ala-His

Met-Ala-His

C14H23N5O4S (357.1471)


   

Val-Cys-His

Val-Cys-His

C14H23N5O4S (357.1471)


   

Val-His-Cys

Val-His-Cys

C14H23N5O4S (357.1471)


   

N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-2-[(2-phenoxyacetyl)amino]acetamide

N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-2-[(2-phenoxyacetyl)amino]acetamide

C18H19N3O5 (357.1325)


   

His-Ser-Asp

His-Ser-Asp

C13H19N5O7 (357.1284)


   

3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid

3-[(3s,6s,11ar)-1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl]propanoic acid

C15H23N3O5S (357.1358)


   

3-{1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl}propanoic acid

3-{1,4-dihydroxy-3-[2-(methylsulfanyl)ethyl]-7-oxo-3h,6h,9h,10h,11h,11ah-pyrrolo[1,2-a][1,4,7]triazonin-6-yl}propanoic acid

C15H23N3O5S (357.1358)


   

2-({4-ethenyl-8-hydroxy-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyridin-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4-ethenyl-8-hydroxy-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyridin-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23NO8 (357.1424)